Cargando…

Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Clostridium Difficile (RAPID): a randomised placebo controlled trial

BACKGROUND: Clostridium difficile infection (CDI) recurs after initial treatment in approximately one in four patients. A single-centre pilot study suggested that this could be reduced using ‘follow-on’ rifaximin treatment. We aimed to assess the efficacy of rifaximin treatment in preventing recurre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Major, Giles, Bradshaw, Lucy, Boota, Nafisa, Sprange, Kirsty, Diggle, Mathew, Montgomery, Alan, Jawhari, Aida, Spiller, Robin C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Colon
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582824/ https://www.ncbi.nlm.nih.gov/pubmed/30254135 http://dx.doi.org/10.1136/gutjnl-2018-316794

Ejemplares similares

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea
por: Weiss, Karl, et al.
Publicado: (2015)

Rifaximin Therapy for Patients With Metronidazole-Unresponsive Clostridium difficile Infection
por: Waqas, Muhammad, et al.
Publicado: (2022)

Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile
por: Huhulescu, Steliana, et al.
Publicado: (2011)

Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin
por: Lao, Dominador, et al.
Publicado: (2012)

Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin
por: Tannous, George, et al.
Publicado: (2010)

Genetic architectures of proximal and distal colorectal cancer are partly distinct
por: Huyghe, Jeroen R, et al.
Publicado: (2021)

TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres
por: Jones, A M, et al.
Publicado: (2011)

Performance measures in three rounds of the English bowel cancer screening pilot
por: Moss, S M, et al.
Publicado: (2011)

Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population
por: Cui, R, et al.
Publicado: (2011)

Colorectal cancer screening with odour material by canine scent detection
por: Sonoda, Hideto, et al.
Publicado: (2011)

Suppression of tumour-specific CD4(+) T cells by regulatory T cells is associated with progression of human colorectal cancer
por: Betts, Gareth, et al.
Publicado: (2011)

A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction
por: Tian, Sun, et al.
Publicado: (2013)

Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models
por: Hackl, Christina, et al.
Publicado: (2013)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013)

miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer
por: Ji, Shunlong, et al.
Publicado: (2013)

Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation
por: Lourenço, Filipe C, et al.
Publicado: (2014)

Source of dietary fibre and diverticular disease incidence: a prospective study of UK women
por: Crowe, Francesca L, et al.
Publicado: (2014)

Prevention and treatment of colon cancer by peroral administration of HAMLET (human α-lactalbumin made lethal to tumour cells)
por: Puthia, Manoj, et al.
Publicado: (2014)

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
por: Church, Timothy Robert, et al.
Publicado: (2014)

Canonical Wnt signals combined with suppressed TGFβ/BMP pathways promote renewal of the native human colonic epithelium
por: Reynolds, Amy, et al.
Publicado: (2014)

Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines
por: Davis, Hayley, et al.
Publicado: (2014)

Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer
por: Yu, Jun, et al.
Publicado: (2015)

Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme
por: Lo, Siu Hing, et al.
Publicado: (2015)

A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS
por: Rosmarin, Dan, et al.
Publicado: (2015)

Initial US evaluation of second-generation capsule colonoscopy for detecting colon polyps
por: Morgan, Douglas R, et al.
Publicado: (2016)

The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon
por: Grimm, Wesley A, et al.
Publicado: (2016)

Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer
por: Xu, Lixia, et al.
Publicado: (2016)

Low-residue breakfast during the preparation for colonoscopy using a polyethylene glycol electrolyte solution: a randomised non-inferiority trial
por: Flemming, Jennifer A, et al.
Publicado: (2015)

Severe colic mimicking intussusception: a new phenomenon
por: El-Gohary, Mohamed Amin
Publicado: (2015)

Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study
por: van Heijningen, Else-Mariëtte B, et al.
Publicado: (2015)

Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program
por: Chiu, Sherry Yueh-Hsia, et al.
Publicado: (2017)

Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C
por: Müller, Thomas, et al.
Publicado: (2016)

Randomised clinical study comparing the effectiveness and physiological effects of hypertonic and isotonic polyethylene glycol solutions for bowel cleansing
por: Yamano, Hiro-o, et al.
Publicado: (2016)

Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP–WT1–TBL1 axis
por: Zhang, Jingwan, et al.
Publicado: (2016)

Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
por: Mowat, Craig, et al.
Publicado: (2016)

High hospital research participation and improved colorectal cancer survival outcomes: a population-based study
por: Downing, Amy, et al.
Publicado: (2017)

How bad is bile acid diarrhoea: an online survey of patient-reported symptoms and outcomes
por: Bannaga, Ayman, et al.
Publicado: (2017)

MED12 is recurrently mutated in Middle Eastern colorectal cancer
por: Siraj, Abdul K, et al.
Publicado: (2018)

CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells
por: Manic, Gwenola, et al.
Publicado: (2018)

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
por: Møller, Pål, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vmc4qe7rjjivk1ipr6pgtm4v8m